Nilesh Gupta, Managing Director, Lupin said, ''The OTC segment is one of the fastest growing segments in the Indian pharmaceutical market. This, combined with our capabilities and expertise in this space, makes it a lucrative business opportunity for Lupin. Our long term strategy is to have a portfolio of ...
Read more: Lupin forays into the OTC segment with Softovac